Why would international or Australian pharmaceutical companies place their trials in Australia when there are providers of the same services in the US?
A recent report commissioned by the federal government rated Clinical Trials Services in Australia as being globally competitive for several reasons: • The cost per subject of clinical trials compares favourably to the US. • Only 10% of US clinical trials are completed on time whereas 80% are completed on time in Australia • The quality of services is equivalent to services in US and Europe. In addition The Clinical Trial Notification (CTN) scheme in Australia is one of the fastest approval processes globally which gives Australia an inherent advantage in timeliness of delivery. For first time in man studies US companies need not have an IND. This allows US companies to perform first time in man studies in Australia (with appropriate IB) without commiting to an IND.
Related Questions
- Im a manufacturer based outside Australia, how can BRM Services help me get business in the Australian Electrical Industry?
- How does the Australian Government represent Australias interests in international telecommunications?
- What Australian plumbing companies sponsor UK plumbers to work in Australia?
